Contact
Please use this form to send email to PR contact of this press release:
Silexion Therapeutics Announces 1-for-9 Reverse Share Split
TO:
Please use this form to send email to PR contact of this press release:
Silexion Therapeutics Announces 1-for-9 Reverse Share Split
TO: